6 results about "Insulin delivery device" patented technology

A technique for treating diabetes that recognizes patient insulin sensitivity is a time-varying physiological parameter. The described techniques for treating diabetes include measuring interstitial fluid glucose concentration, reading insulin delivery data, determining patient insulin sensitivity based on the interstitial fluid glucose concentration and insulin delivery data, and a time-varying physiological parameter, and dispensing an insulin dose from an insulin delivery device based on the determined patient insulin sensitivity.

In an aspect, the present disclosure provides an insulin delivery device configured to be positioned on a body of a subject via a single puncture site in said body of said subject, wherein said insulin delivery device is configured to deliver an insulin or insulin analog formulation to said subject via said single puncture site, wherein said insulin delivery device comprises a sensor configured to measure a glucose concentration in said body of said subject via said single puncture site, and wherein said delivering and said measuring are performed at substantially the same time for a time period of at least 1 hour subsequent to said positioning, while maintaining a sensitivity of said sensor of at least 50% of an initial sensitivity of said sensor.

The application relates to the technical field of biomedical engineering, and particularly discloses a portable insulin administration device, which comprises a non-invasive blood glucose detection module arranged from bottom to top and used for monitoring human blood glucose concentration based on a counter-ion electro-osmosis technology; a drug loading module used for loading drugs, wherein the drugs comprise insulin; and a transdermal administration module connected with the drug loading module and used for applying a pulse voltage to skin to enhance the transdermal penetration efficiency of the skin and drive the drugs in the drug loading module to penetrate into a dermis layer when the monitored blood glucose concentration value is greater than a preset threshold value. The device adopts the counter-ion electro-osmosis technology to monitor the human blood glucose concentration in real time, and realizes transdermal delivery of insulin through the electroporation technology, so that the two functions of blood glucose concentration monitoring and insulin delivery are combined, the integration of symptom diagnosis and treatment is realized, and both functions can be realized in a completely non-invasive manner without causing damage to the skin of a patient.

Abstract A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device. USER Sensor Sensor Data Data GLUCOSE SENSOR SYSTEM 101 v SECOND FIRST ACCESSORY ACCESSORY MOBILE 103 102 APPLICATION g 104 MANUEL MANUEL DELIVERY DELIVERY DEVICE DEVICE 107 106 108 WEB x SERVICES 105 FIG. 1A 20 24 22 75 63 23 O ct 2 02 4 2 0 2 4 2 2 7 5 6 3 2 3 O c t 2 0 2 4 U S E R S e n s o r S e n s o r W O 2 0 1 9 / 1 1 8 5 3 1 D a t a G L U C O S E D a t a S E N S O R S Y S T E M 1 0 1 S U B S T I T U T E S H E E T ( R U L E 2 6 ) F I R S T S E C O N D A C C E S S O R Y A C C E S S O R Y M O B I L E 1 0 2 1 0 3 A P P L I C A T I O N 1 / 3 9 1 0 4 M A N U E L M A N U E L D E L I V E R Y D E L I V E R Y D E V I C E D E V I C E 1 0 6 1 0 7 1 0 8 W E B S E R V I C E S 1 0 5 P C T / U S 2 0 1 8 / 0 6 5 0 6 7 F I G . 1 A

A method may include displaying at least three icons on a user interface of a mobile device, including a first icon associated with the at least three icons associated with a first carbohydrate level, a second icon associated with the at least three icons associated with a second carbohydrate level, and a third icon associated with the at least three icons associated with a third carbohydrate level. The method may also include receiving a user selection of one of the three icons through the user interface of the mobile device, and determining an insulin bolus level from the user selection. The method may also include communicating the insulin bolus level to an insulin delivery device.

A method may include displaying at least three icons on a user interface of a mobile device, including a first icon associated with the at least three icons associated with a first carbohydrate level, a second icon associated with the at least three icons associated with a second carbohydrate level, and a third icon associated with the at least three icons associated with a third carbohydrate level. The method may also include receiving a user selection of one of the three icons through the user interface of the mobile device, and determining an insulin bolus level from the user selection. The method may also include communicating the insulin bolus level to an insulin delivery device.